These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 590312)

  • 1. The influence of prolonged treatment with D-penicillamine on the immune response in Wilson's disease.
    Czlonkowska A
    Eur J Clin Pharmacol; 1977 Dec; 12(4):265-71. PubMed ID: 590312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological observations on patients with Wilson's disease.
    Czlonkowska A; Milewski B
    J Neurol Sci; 1976 Oct; 29(2-4):411-21. PubMed ID: 978218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The detection of antibodies against D-penicillamine. 3. Detection of antibodies against D-penicillamine in the serum of patients with Wilson's disease treated with D-penicillamine--preliminary results].
    Trautmann B; Storch W
    Pharmazie; 1986 Feb; 41(2):126-7. PubMed ID: 3523546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serious side effects with D-penicillamine therapy for Wilson's disease].
    Storch W; Lössner J; Ruchholtz U
    Psychiatr Neurol Med Psychol (Leipz); 1979 Sep; 31(9):531-8. PubMed ID: 161403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute lymphoblastic leukemia in a patient receiving penicillamine for Wilson's disease.
    Gilman PA; Holtzman NA
    JAMA; 1982 Jul; 248(4):467-8. PubMed ID: 6953259
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunologic studies with the lymphocyte transformation test on the side effects of D-penicillamine therapy in Wilson's disease].
    Storch W; Berger H
    Z Gesamte Inn Med; 1980 Jul; 35(13):567-70. PubMed ID: 7445606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of long-term treatment with d-penicillamine on the humoral immune response in patients with Wilson's disease.
    Czlonkowska A
    Mater Med Pol; 1976; 8(1):48-50. PubMed ID: 1263584
    [No Abstract]   [Full Text] [Related]  

  • 8. D-penicillamine-induced IgA deficiency in Wilson's disease.
    Proesmans W; Jaeken J; Eeckels R
    Lancet; 1976 Oct; 2(7989):804-5. PubMed ID: 61477
    [No Abstract]   [Full Text] [Related]  

  • 9. [T-rosette test in Wilson's disease].
    Czlonkowska A
    Neurol Neurochir Pol; 1975; 9(4):441-6. PubMed ID: 1101097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [immunohistologic findings of kidney biopsies in Wilson's disease].
    Storch W; Ditscherlein G; Lange E; Lössner J
    Z Urol Nephrol; 1980 Mar; 73(3):181-90. PubMed ID: 7434982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The immune competence of patients with Crohn's disease (author's transl)].
    Tönnesmann E; Bürkle PA; Schäfer B; Federlin K
    Klin Wochenschr; 1979 Oct; 57(20):1097-107. PubMed ID: 513603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immune response during aging.
    Członkowska A; Korlak J
    J Gerontol; 1979 Jan; 34(1):9-14. PubMed ID: 310440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of therapeutic irradiation on the immune responses.
    Slater JM; Ngo E; Lau BH
    AJR Am J Roentgenol; 1976 Feb; 126(2):313-20. PubMed ID: 175700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dermal alterations in patients with Wilson's disease treated with D-penicillamine.
    Pasquali Ronchetti I; Quaglino D; Baccarani Contri M; Hayek J; Galassi G
    J Submicrosc Cytol Pathol; 1989 Jan; 21(1):131-9. PubMed ID: 2702608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypothyroidism and dyshormonogenesis induced by D-penicillamine in children with Wilson's disease and healthy infants born to a mother with Wilson's disease.
    Hanukoglu A; Curiel B; Berkowitz D; Levine A; Sack J; Lorberboym M
    J Pediatr; 2008 Dec; 153(6):864-6. PubMed ID: 19014823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [D-penicillamine-induced IgA deficiency in the therapy of Wilson's disease].
    Ibel H; Feist D; Endres W; Belohradsky BH
    Klin Padiatr; 1990; 202(6):427-9. PubMed ID: 2266710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [On hepatolenticular degeneration (Wilson's disease). II. Treatment of 2 cases of Wilson's disease for 8 months with D-penicillamine].
    Germinario L; Campanella G; D'Addabbo A
    Acta Neurol (Napoli); 1971; 26(4):423-35. PubMed ID: 5132824
    [No Abstract]   [Full Text] [Related]  

  • 18. Reduction of immune complexes and immunoglobulins induced by D-penicillamine in primary biliary cirrhosis.
    Epstein O; De Villiers D; Jain S; Potter BJ; Thomas HC; Sherlock S
    N Engl J Med; 1979 Feb; 300(6):274-8. PubMed ID: 759879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Red cell aplasia following prolonged D-penicillamine therapy.
    Gollan JL; Hussein S; Hoffbrand AV; Sherlock S
    J Clin Pathol; 1976 Feb; 29(2):135-9. PubMed ID: 819461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of oral D-penicillamine treatment on experimental arthritis and the associated immune response in rabbits. II. The effects on cellular parameters.
    Hunneyball IM; Stewart GA; Stanworth DR
    Immunology; 1978 Jul; 35(1):159-66. PubMed ID: 680799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.